Gibson Dunn Advises North Immunology on Merger With Aethlon Medical, Concurrent Private Placement
Firm News | September 17, 2026
Gibson Dunn is advising North Immunology, Inc. on its merger with Aethlon Medical, Inc., along with a concurrent private placement expected to fund the combined company’s operations into the second half of 2028.
The Gibson Dunn corporate team is led by partners Ryan Murr and Branden Berns and includes of counsel Evan Shepherd and associates Gerald Kimani, Anika Gidwani, and Kriti Hannon. Partner Pamela Lawrence Endreny is advising on tax aspects, and partner Sean Feller is advising on benefits. Partner Aaron Briggs is advising on securities regulation and corporate governance aspects. Partners Bradley Smith and Michelle Gourley are advising on antitrust aspects.